| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q37351453 | A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle |
| Q30434796 | A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers |
| Q35992219 | A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis |
| Q37420525 | A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. |
| Q35743883 | A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. |
| Q43104986 | ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis |
| Q37274810 | AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma |
| Q59661791 | Abstract 1546: Effective co-targeting of tumor and tumor stroma for head and neck cancer treatment: making the right combination |
| Q77844187 | Acellular dermal matrix allografts to achieve increased attached gingiva. Part 2. A histological comparative study |
| Q47697133 | Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association |
| Q33320268 | Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications |
| Q80301619 | Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1 |
| Q83395063 | Assuring dental student head and neck cancer screening competency |
| Q88218762 | Authors' response |
| Q62336484 | Bcl-2 Orchestrates a Cross-talk between Endothelial and Tumor Cells that Promotes Tumor Growth |
| Q84892754 | Brush-based cytology screening in the tonsils and cervix: there is a difference! |
| Q54299346 | CD34 and α smooth muscle actin distinguish verrucous hyperplasia from verrucous carcinoma. |
| Q84780100 | Can saliva-based HPV tests establish cancer risk and guide patient management? |
| Q80842769 | Cause-related marketing: the uneasy alliance between altruism and corporate greed |
| Q88942040 | Changing of the guard |
| Q35613632 | Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer |
| Q38820153 | Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck |
| Q73290640 | Classification and identification of genes associated with oral cancer based on gene expression profiles. A preliminary study |
| Q24197586 | Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults |
| Q24202313 | Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults |
| Q90226981 | Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma |
| Q36713817 | Critical evaluation of diagnostic aids for the detection of oral cancer |
| Q39253056 | Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers |
| Q35206363 | DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer |
| Q24187750 | Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions |
| Q24202596 | Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions |
| Q83212916 | Direct-to-consumer advertising for oral cancer screening devices |
| Q36129640 | Dual Inhibition of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor is an Effective Chemopreventive Strategy in the Mouse 4-NQO Model of Oral Carcinogenesis |
| Q39570656 | Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin |
| Q73571253 | Endothelial cell migration assay. A quantitative assay for prediction of in vivo biology |
| Q33990915 | Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer |
| Q36631786 | Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. |
| Q93195075 | Evaluation of In Situ Hardening β-Tricalcium Phosphate/Poly(lactic-co-glycolide) Bone Substitute Used in Edentulous Ridge Preservation for Late Implant Placement: Case Series |
| Q49668969 | Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental Association. |
| Q37740827 | Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas |
| Q61851260 | Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas |
| Q38380044 | Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma |
| Q45996599 | Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. |
| Q43083986 | Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition |
| Q46036998 | Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. |
| Q36462233 | Gene expression levels in different stages of progression in oral squamous cell carcinoma |
| Q30852806 | Gene expression profiling using laser capture microdissection |
| Q41496425 | Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. |
| Q33707852 | Granulocyte colony-stimulating factor blockade enables dexamethasone to inhibit lipopolysaccharide-induced murine lung neutrophils |
| Q35984721 | Head and neck cancer: the pursuit of molecular diagnostic markers |
| Q91135970 | Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma |
| Q91315855 | Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline |
| Q36129672 | Identification and characterization of the human NOL7 gene promoter |
| Q30497051 | Identification and functional analysis of NOL7 nuclear and nucleolar localization signals |
| Q92677380 | Immune profiles in primary squamous cell carcinoma of the head and neck |
| Q34420593 | Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma |
| Q80818544 | Improving translational research for oral cancer screening aids: putting my "money" where my mouth is |
| Q34790902 | Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. |
| Q41607812 | Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes |
| Q35008028 | Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas |
| Q36677180 | Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy |
| Q37046518 | Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC |
| Q43501670 | Journal alliance to address issues of dual submission and plagiarism |
| Q85632152 | Journal alliance to address issues of dual submission and plagiarism |
| Q95481275 | Journal alliance to address issues of dual submission and plagiarism |
| Q95487316 | Journal alliance to address issues of dual submission and plagiarism |
| Q43441046 | Journal alliance to address issues of dual submission and plagiarism. |
| Q36636330 | Lessons learned from psoriatic plaques concerning mechanisms of tissue repair, remodeling, and inflammation |
| Q84300814 | Looking back as we move forward |
| Q54494258 | Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. |
| Q102335178 | Making oral pathology lemonade from COVID-19 lemons |
| Q52607160 | Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. |
| Q94462685 | Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful? |
| Q88514757 | Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications |
| Q91507576 | Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis |
| Q33549710 | Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis |
| Q35788662 | Neuropilin-1 participates in wound angiogenesis |
| Q58607867 | Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy |
| Q36070536 | Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis |
| Q35166954 | Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer |
| Q85273964 | Odontogenic myxoma of the face: mimicry of cherubism |
| Q33661428 | Oral cancer and oral potentially malignant disorders |
| Q79596110 | Oral cancer screening aids: where is the science? |
| Q92147110 | Oral leukoplakia and risk of progression to oral cancer: A population-based cohort study |
| Q36801074 | PTEN deficiency contributes to the development and progression of head and neck cancer. |
| Q28263339 | Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion |
| Q33864138 | Periostin is upregulated in coronary arteriopathy in Kawasaki disease and is a potential diagnostic biomarker. |
| Q28305880 | Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers |
| Q92543309 | Plasmacytoid cells in salivary pleomorphic adenoma: an alternative interpretation of their immunohistochemical characteristics highlights function and capability for epithelial-mesenchymal transition |
| Q40673052 | Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. |
| Q84215581 | Point of care salivary diagnostics for systemic disease screening: if someone builds it, will dentistry come? |
| Q83169898 | Pragmatics versus contrarians: how does one resolve their differences with respect to oral cancer screening? |
| Q78710242 | Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling |
| Q35870112 | Prevalidation of salivary biomarkers for oral cancer detection |
| Q57643748 | Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies |
| Q104796711 | Proliferative Verrucous Leukoplakia: An Expert Consensus Guideline for Standardized Assessment and Reporting |
| Q40266943 | Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase |
| Q35759998 | Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery |
| Q36863978 | Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing |
| Q42775567 | Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma |
| Q82449101 | Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin |
| Q46813416 | Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. |
| Q96129479 | Response to Brandt, Bednarz-Knoll, Kleinheinz et al |
| Q44062544 | Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma |
| Q35187759 | Role of AMP-18 in oral mucositis |
| Q38812741 | Screening for oral cancer-a perspective from the Global Oral Cancer Forum. |
| Q44383187 | Screening for oral premalignancy and cancer: what platform and which biomarkers? |
| Q90210020 | Society of Behavioral Medicine position statement: Society of Behavioral Medicine supports oral cancer early detection by all healthcare providers |
| Q91921739 | Somatic mitochondrial mutation discovery using ultra-deep sequencing of the mitochondrial genome reveals spatial tumor heterogeneity in head and neck squamous cell carcinoma |
| Q34561572 | Synchronous benign and malignant salivary gland tumors in ipsilateral glands: a report of two cases and a review of literature |
| Q51799068 | Synthetic peptides derived from the angiostatin K4 domain inhibit endothelial cell migration. |
| Q52006342 | Tales of academic dishonesty and what do we do about it? |
| Q30494514 | The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma |
| Q36520728 | The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7 |
| Q89565809 | The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma |
| Q81791905 | The changing face of head and neck cancer |
| Q35760433 | The expanding role of systemic therapy in head and neck cancer |
| Q36383442 | The transcriptional profile of coronary arteritis in Kawasaki disease |
| Q33631866 | Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization |
| Q37077763 | Tissue microarray - a high-throughput molecular analysis in head and neck cancer |
| Q93351924 | Triple O Content Innovations and New Section Editors |
| Q86203521 | Triple O has gone virtual! |
| Q44883097 | Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity |
| Q104752904 | Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma |
| Q81146709 | Update in head and neck oncology |
| Q36213589 | Validation of LOH profiles for assessing oral cancer risk. |
| Q46497166 | Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials |
| Q38950752 | WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. |
| Q37520610 | WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck |
| Q37593319 | WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer |
| Q91421888 | We have a "ring around the collar" problem |
| Q86985219 | Welcome R. Bryan Bell, DDS, MD, FACS, FACD |
| Q28540464 | p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors |
Search more.